Healthcare

•Board reassessment has identified a potential 510(k) clearance pathway for the Felix™ Sperm Separation System, replacing the previously contemplated De Novo classification route, following the identification of a potential predicate device.

• 561 Australian ChemistWarehousebranded stores reached, with 24 new stores and 18 refurbishments during FY26; like-for-like sales +13.4%.

Mesoblast Limited (ASX:MSB) is a biotechnology company developing allogeneic, off-the-shelf cellular medicines for severe and life-threatening inflammatory conditions. The company’s proprietary mesenchymal lineage cell therapy platform focuses on reducing inflammatory processes by releasing anti-inflammatory factors that modulate immune responses.

The combination of pharmaceutical wholesale and a large pharmacy retail network has reshaped Sigma Healthcare’s operating scale. Sigma Healthcare (ASX:SIG) supplies pharmaceutical, medical, healthcare and beauty products while supporting pharmacy brands that include Chemist Warehouse, Amcal and Discount Drug Stores. Integration, store expansion and …

•Net Incomeincreased to US$1,523 million (US$10.43 per diluted share), up from US$1,401 million (US$9.51) in FY25.

• Operating NPAT surged 50.1% to $47.4 million, with Operating Diluted EPS growing 23.6% to 12.6 cents.

The formal request was submitted to Ms Renee Hutchens, Senior Adviser, Listings Supervision at ASX Limited, pursuant to ASX Listing Rule 17.1. The halt will remain in place until the earlier of Healius making the announcement or the commencement of trading on Monday, 28 …